home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

342 rows where filing_period = "second_quarter", filing_year = 2021 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • MED · 342 ✖

filing_year 1

  • 2021 · 342 ✖

filing_period 1

  • second_quarter · 342 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2631970 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) fdecb3ae-a259-4ac1-846c-18cc6fe57d10 Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2021 second_quarter MED Pharmaceutical Labeling Food & Drug Administration (FDA) 18700   0 0 2021-06-23T10:39:25.087000-04:00
2631997 AMERICAN PHYSICAL THERAPY ASSOCIATION bef03368-249c-41b4-8225-13d655297441 2T AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2021 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Outpatient Therapy Modernization and Stabilization Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   240544 0 1 2021-06-25T09:52:10.103000-04:00
2632273 FRANCIS EDWARD & CRONIN, INC. 66f736da-7d49-467d-bb36-14a05dd6edb7 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2021 second_quarter MED Issues and legislation related to Alzheimer's disease research Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2021-07-01T09:53:33.307000-04:00
2632276 FRANCIS EDWARD & CRONIN, INC. f24ab1b1-d450-4e87-8b44-f0f1d1c05922 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2021 second_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA)     0 0 2021-07-01T09:58:34.297000-04:00
2632361 THE CONSILIO GROUP 06f37596-32d4-46b2-8b7f-b8446d8b1cb1 Q2 THE CONSILIO GROUP 400374717 DETECTACHEM 2021 second_quarter MED Chemical detection test for COVID-19 Air Force, Dept of,Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Education, Dept of,Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),White House Office 16500   0 0 2021-07-01T12:15:00.977000-04:00
2632591 THE HARRIS FIRM 1c3a9db0-458f-4ac9-861d-b4fc438bda4c Q2 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2021 second_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-02T13:40:44.710000-04:00
2632758 MARSHALL BRACHMAN 86cfceb4-0d29-4dd5-8934-c1395cab5f55 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2021 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2021-07-03T15:53:50.993000-04:00
2632832 MOLNLYCKE HEALTH CARE US, LLC 1ca2ec1d-9283-436b-b30f-462ef76aed89 Q2 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2021 second_quarter MED Personal Protective Equipment and Medical Research HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2021-07-05T10:43:32.123000-04:00
2632986 MAGILL ASSOCIATES, LLC deb5f848-e932-4b4a-befa-d57d287e9e3f 2A MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2021 second_quarter MED FY'22 defense appropriations bill for the development of a synthetic vaccine Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-06T11:12:42.737000-04:00
2633950 AMERICAN COLLEGE OF CLINICAL PHARMACY c73ff5b5-3718-401f-b944-79b0cd238fdc Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-07-08T09:10:46.310000-04:00
2634056 WATKINS & EAGER PLLC 405bcdbc-4f48-4315-a4ce-2ea829d33670 Q2 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2021 second_quarter MED Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-07-08T11:03:31.277000-04:00
2634139 THE PRENDA GROUP LLC a393a0e2-d896-4066-b28c-8f40ce190bd1 Q2 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2021 second_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-08T13:24:57-04:00
2634182 THE CONAFAY GROUP, LLC a1480461-ad52-431a-ba2c-e8a9d207f33a Q2 THE CONAFAY GROUP, LLC 401004840 HAWAII BIOTECH, INC. 2021 second_quarter MED seek support for medical countermeasures. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-08T14:26:43.340000-04:00
2634201 THE CONAFAY GROUP, LLC 26863a99-da31-4105-bb69-32347f74fbcf Q2 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2021 second_quarter MED Pharmaceutical Research   10000   0 0 2021-07-08T15:02:01.997000-04:00
2634209 THE SPECTRUM GROUP c2865427-bdf1-4345-8926-6328d4bcf8a1 Q2 THE SPECTRUM GROUP 36300 SCONE MEDICAL SOLUTIONS 2021 second_quarter MED Congressional awareness and support of FDA and VHA approval and use of self-contained negative pressure device for COVID-19 and other infectious diseases.       0 0 2021-07-08T15:07:05.553000-04:00
2634215 THE CONAFAY GROUP, LLC 96e81455-a7b1-4422-9533-995bd4132900 Q2 THE CONAFAY GROUP, LLC 401004840 LUNGPACER MEDICAL USA, INC 2021 second_quarter MED seek support for research and development funding. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS)     0 0 2021-07-08T15:15:11.387000-04:00
2634229 THE CONAFAY GROUP, LLC 2a4f5de6-e1e3-49ae-a4ed-b4e0f8040888 Q2 THE CONAFAY GROUP, LLC 401004840 MESOTHELIOMA APPLIED RESEARCH FOUNDATION 2021 second_quarter MED Support for Mesothelioma research HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-08T15:27:19.237000-04:00
2634237 THE CONAFAY GROUP, LLC 3df2f282-c65f-4d36-ba30-f86122d7365d Q2 THE CONAFAY GROUP, LLC 401004840 CENTIVAX 2021 second_quarter MED support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-08T15:33:27.160000-04:00
2634240 THE CONAFAY GROUP, LLC 4c80cd72-74ea-4b66-b0e3-cf3753308df5 Q2 THE CONAFAY GROUP, LLC 401004840 ROIVANT SCIENCES, INC. 2021 second_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-08T15:36:31.527000-04:00
2634243 THE CONAFAY GROUP, LLC 73eddd35-3aba-45e2-b78d-965244f615e2 Q2 THE CONAFAY GROUP, LLC 401004840 ATEA PHARMACEUTICALS, INC. 2021 second_quarter MED Support for medical/disease research.   30000   0 0 2021-07-08T15:39:32.620000-04:00
2634244 THE CONAFAY GROUP, LLC 59538c79-fd4f-4076-9431-bd07595fc41b Q2 THE CONAFAY GROUP, LLC 401004840 CURIA GLOBAL, INC. (FORMERLY KNOWN AS ALBANY MOLECULAR RESEARCH, INC.) 2021 second_quarter MED Federal support to advance medical research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-08T15:45:34.737000-04:00
2634257 THE CONAFAY GROUP, LLC 8b9357dc-9e1b-4bc1-af8b-7d3ec56b11a7 Q2 THE CONAFAY GROUP, LLC 401004840 THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) 2021 second_quarter MED Support for trauma research HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-08T15:56:44.240000-04:00
2634295 NATURAL RESOURCE RESULTS LLC 8cb5561c-fe16-408b-9f18-bff635d6975a Q2 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2021 second_quarter MED Support funding at NNSA for Moly-99 domestic production facility construction. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-08T16:36:24.450000-04:00
2634503 GOLDBUG STRATEGIES LLC ab48b824-7920-4d0e-8db5-485888216c0b Q2 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2021 second_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 5500   0 0 2021-07-09T10:04:20.547000-04:00
2634548 EFB ADVOCACY, LLC 6e373dbc-3ce2-4f3e-9a6f-b334a09e0b2b Q2 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2021 second_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-09T10:29:46.633000-04:00
2634847 BUCHANAN INGERSOLL & ROONEY PC 4345b1f6-8267-4df4-ad55-f7eb1861f7f1 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 AMIVAS, LLC 2021 second_quarter MED FDA post-approval of malaria products Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-10T06:14:49.980000-04:00
2634858 BUCHANAN INGERSOLL & ROONEY PC b74668fc-880d-4f22-8ce7-cae67bc2124f Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2021 second_quarter MED Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-10T07:15:57.160000-04:00
2634904 BEN BARNES GROUP LP 6d8c1fba-f810-44aa-a751-f98317e543f7 Q2 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2021 second_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-07-10T12:33:38.217000-04:00
2635109 RYAN COSTELLO STRATEGIES f584ac78-3c08-415d-a625-7c6dd43ab80e Q2 RYAN COSTELLO STRATEGIES 401105569 CARDIOL THERAPEUTICS 2021 second_quarter MED No specific lobbying issues this quarter, determining applicable research grant opportunities HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2021-07-12T11:20:01.937000-04:00
2635414 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 5545ed2d-887c-4ea9-b83d-10f781399373 Q2 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2021 second_quarter MED Funding for COVID treatments and research Funding of federally-sponsored research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   203000 0 0 2021-07-12T15:29:11.500000-04:00
2635699 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 492adc95-7edd-4958-9691-1529e545aa25 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2021 second_quarter MED Support for the National Institutes of Health; Support for the National Eye Institute; Support for medical research activities at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   63271 0 0 2021-07-13T08:56:39.763000-04:00
2636281 IMPACT MANAGEMENT GROUP bc3f99b9-3b7e-4e1b-ab67-d4bc3fff554a Q2 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2021 second_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE 7800   0 0 2021-07-13T16:18:50.383000-04:00
2636548 MCHUGH LEMAY ASSOC., LLC 860b6c8d-642a-4194-9278-de9d9fbd4348 Q2 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 second_quarter MED Issues related to COVID testing - no specific legislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-14T09:08:03.423000-04:00
2636567 NEOGENOMICS LABORATORIES 0b1d2a53-899c-4d72-9df2-4bdb6a8e0864 Q2 NEOGENOMICS LABORATORIES 401105014 NEOGENOMICS LABORATORIES 2021 second_quarter MED Verifying Accurate Leading-edge IVCT Development Act of 2020, S. 3404 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-14T09:21:05.953000-04:00
2636993 WAKE FOREST UNIVERSITY HEALTH SCIENCES cda26b7e-da45-4d03-86d2-5f15a6f1ead1 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2021 second_quarter MED 340 (b) program guidelines; HRSA community project funding; "Research Investment to Spark the Economy" (RISE) Act; "US Citizenship Act of 2021"; Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2021-07-14T13:57:04.287000-04:00
2637181 FEDERAL SOLUTIONS, LLC 4487e572-80a0-4d98-a216-827019fdf11c Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2021 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2021-07-14T15:48:06.500000-04:00
2637245 STANFORD UNIVERSITY b41fbf84-a6c7-4b57-ab1d-8869d0f7f197 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2021 second_quarter MED H.R.708; S168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 Title VII HRSA Health Professions programs Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2021-07-14T16:04:20.130000-04:00
2637499 MICHIGAN TECHNOLOGICAL UNIVERSITY 8ff4c9ba-478d-4910-9476-5fea3f42e4d5 Q2 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2021 second_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2021-07-15T08:22:44.590000-04:00
2637963 THE JACKSON LABORATORY c921ce3f-6ace-416a-b91f-8af207cdb490 Q2 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2021 second_quarter MED Issues related to biomedical research, and animals used in biomedical research. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   30000 0 0 2021-07-15T13:34:16.417000-04:00
2638009 BRACEWELL LLP 734af346-4330-4f77-94d6-1af2f30c4ae0 Q2 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2021 second_quarter MED Brain tumor and childhood cancer legislation; drug pricing and shortages; COVID-19 response issues Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-15T13:50:29.500000-04:00
2638241 COVINGTON & BURLING LLP 394fe7b8-2c48-4c49-9875-b6b419b58abd Q2 COVINGTON & BURLING LLP 11195 ZYMERGEN INC. 2021 second_quarter MED Enhanced investment in biomanufacturing; investment in workforce development, infrastructure, and R&D for synthetic biology; shoring up manufacturing supply chains for critical pharmaceutical ingredients; supporting government investment in mRNA-based technologies HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-07-15T14:40:39.937000-04:00
2638317 STRATEGIC MARKETING INNOVATIONS c8e18b69-4445-4828-a172-4cabcf01114d Q2 STRATEGIC MARKETING INNOVATIONS 60550 IGM BIOSCIENCES, INC. 2021 second_quarter MED Antibody therapy for COVID-19 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-15T15:00:55.590000-04:00
2638322 STRATEGIC MARKETING INNOVATIONS 670564ff-78c9-4893-af60-a29d179c51d4 2T STRATEGIC MARKETING INNOVATIONS 60550 INTRIVO DIAGNOSTICS 2021 second_quarter MED Antigen Testing Technology HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2021-07-15T15:02:57.543000-04:00
2638414 MANATT, PHELPS, AND PHILLIPS 3aeeb5ca-f4f3-4936-872c-80792b30b783 Q2 MANATT, PHELPS, AND PHILLIPS 23645 MEDISYS HEALTH NETWORK 2021 second_quarter MED Medical Disease research       0 0 2021-07-15T15:18:24.397000-04:00
2638494 THOMPSON ADVISORY GROUP 4914c4b9-cfac-40bb-a628-3d45f4bb1f80 Q2 THOMPSON ADVISORY GROUP 319610 SONNET BIOTHERAPEUTICS 2021 second_quarter MED medical research SENATE 10000   0 0 2021-07-15T15:33:43.477000-04:00
2638678 MEEKS, BUTERA & ISRAEL PLLC 4303dd85-2292-4dcc-8cd4-704f0e2d3351 Q2 MEEKS, BUTERA & ISRAEL PLLC 401105818 SOCIETY FOR BRAIN MAPPING & THERAPEUTICS (SBMT) 2021 second_quarter MED Brain technology and medical research issues and programs. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-15T17:16:33.923000-04:00
2638773 TOWNSEND PUBLIC AFFAIRS, INC 68c1f909-1b59-4190-8029-ce6406ffdc77 Q2 TOWNSEND PUBLIC AFFAIRS, INC 54734 CITY OF PARLIER 2021 second_quarter MED health benefits legislation HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,Treasury, Dept of 6000   0 0 2021-07-15T18:09:56.330000-04:00
2638876 MICHAEL N. MCCARTY LAW OFFICE PLLC d2f2be37-075f-4f66-812b-8db0926ea846 Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2021 second_quarter MED Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128; support initiatives to improve clinical laboratory testing supply chains. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-15T19:09:15.287000-04:00
2638890 INFECTIOUS DISEASES SOCIETY OF AMERICA b534d556-0300-4262-a44b-b674bf118d2c Q2 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2021 second_quarter MED Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR Act-S. 2076/H.R. 3932), Verifying Accurate Leading Edge IVCT Development (S. 2209/HR. 4128) Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   96000 0 0 2021-07-15T19:48:17.433000-04:00
2638909 CALIFORNIA LIFE SCIENCES 1d02b87e-eb51-47a6-9890-14d5c440e14a Q2 CALIFORNIA LIFE SCIENCES 7758 CALIFORNIA LIFE SCIENCES 2021 second_quarter MED Support NIH research funding. Support implementation of 21st Century Cures Act. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   110000 0 0 2021-07-15T20:17:20.133000-04:00
2638916 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) e23165a1-9409-4b79-ac33-b0f8d9956dc8 Q2 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2021 second_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA, federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-15T20:20:21.160000-04:00
2638969 SAM ACTION, INC. a503a92b-c3b6-4120-a695-203ecc4fef45 Q2 SAM ACTION, INC. 401104337 SAM ACTION, INC. 2021 second_quarter MED H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Small Business Administration (SBA),White House Office   10000 0 0 2021-07-16T08:20:32.723000-04:00
2639094 DESIMONE CONSULTING, LLC 7bba1add-6018-4a82-ab24-bba0ea7c1b66 Q2 DESIMONE CONSULTING, LLC 400931695 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2021 second_quarter MED Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T09:52:04.333000-04:00
2639395 HACKENSACK MERIDIAN HEALTH d0b87e81-e100-485c-8cf1-ea16ad44cd73 Q2 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2021 second_quarter MED National Institutes of Health funding Biosafety laboratories Support for the Center for Discovery and Innovation Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office   160000 0 0 2021-07-16T11:00:18.920000-04:00
2639424 O'NEILL AND ASSOCIATES 4168fd62-2158-440d-8b29-a3441a353a9d Q2 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2021 second_quarter MED healthcare, medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-07-16T11:06:27.533000-04:00
2639515 IPOLICY SOLUTIONS 2eaa89bc-203d-438a-b9df-d48fa91754fd Q2 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2021 second_quarter MED HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act HOUSE OF REPRESENTATIVES,SENATE 42000   0 0 2021-07-16T11:26:55.637000-04:00
2639516 O'NEILL AND ASSOCIATES 4c72113d-aefa-4534-a06f-eac5d60535d5 Q2 O'NEILL AND ASSOCIATES 73134 ANALOGIC 2021 second_quarter MED medical technology HOUSE OF REPRESENTATIVES,SENATE 20500   0 0 2021-07-16T11:26:56.090000-04:00
2639562 THE LIVINGSTON GROUP, LLC 90625381-dc42-43d9-af5f-769478c4f78f Q2 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2021 second_quarter MED H.R.___ S.___ FY 2022 Defense Appropriations Bill FY 2022 appropriations for the development of a synthetic vaccine Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T11:37:07.927000-04:00
2639568 IPOLICY SOLUTIONS 41a8b5d6-7367-4ea2-af93-726600161fe8 Q2 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2021 second_quarter MED Pharmacogenomic testing CDC Advanced Molecular Detection Program HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 75000   0 0 2021-07-16T11:38:09.770000-04:00
2639715 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 8ebc4c3d-a451-43b2-8228-6ccc02d864f0 Q2 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2021 second_quarter MED NONE HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2021-07-16T12:09:41.647000-04:00
2639753 AMERICAN PHYSICAL THERAPY ASSOCIATION 42113f2c-a05a-4030-998f-9afff2909ec9 Q2 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2021 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Outpatient Therapy Modernization and Stabilization Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   214211 0 0 2021-07-16T12:16:49.190000-04:00
2639856 IMPACT HEALTH POLICY PARTNERS 3ce11120-8ba2-4b80-8e74-f87c25f9e32e Q2 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2021 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-16T12:36:11.340000-04:00
2639862 IMPACT HEALTH POLICY PARTNERS eb2712d2-7782-45b8-9db6-c0dd15b874c5 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2021 second_quarter MED Issues related to research funding, NIH and other matters. HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2021-07-16T12:37:13.363000-04:00
2639880 IMPACT HEALTH POLICY PARTNERS aecd787e-bd56-4f6a-949d-aed1886f2be7 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2021 second_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-16T12:40:17.467000-04:00
2639925 KOUNTOUPES DENHAM CARR & REID, LLC ef3960ff-ea4c-4860-abdc-b9506d98844a Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ICI (INFRARED CAMERAS, INC.) 2021 second_quarter MED Issues relating to bio-risk detection and mitigation using infrared thermal imaging technology. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-16T12:47:28.983000-04:00
2639927 CLARK STREET ASSOCIATES df73539f-eda9-41a5-94e4-88ff1446d095 Q2 CLARK STREET ASSOCIATES 401105692 QORVO 2021 second_quarter MED Issues related to COVID testing - no specific legislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 140000   0 0 2021-07-16T12:48:29.507000-04:00
2640038 COVINGTON & BURLING LLP 4215fccc-9885-453f-9bf1-cea1e325f349 Q2 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2021 second_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2021-07-16T13:14:56.700000-04:00
2640344 MCDERMOTT+ LLC 807badf6-b76a-492d-8a0a-cd3b1aec04c3 Q2 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2021 second_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2021-07-16T14:30:04.320000-04:00
2640802 FORBES-TATE 16746300-916d-4c6d-9c22-0551885abdf0 Q2 FORBES-TATE 400976792 AMGEN USA, INC. 2021 second_quarter MED Issues related to Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T16:04:12.090000-04:00
2640906 FORBES-TATE 5d894fd8-2b21-4fc2-b362-b9d5d38fb1f8 Q2 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 second_quarter MED Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T16:23:35.373000-04:00
2641106 FOLEY & LARDNER LLP e41b406c-d624-45f9-a78b-e7f0e99a7e91 Q2 FOLEY & LARDNER LLP 15042 22ND CENTURY GROUP INC 2021 second_quarter MED FDA Regulatory Issues HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-16T16:58:42.423000-04:00
2641303 TIDES GROUP, LLC af89364d-cf1a-4cbf-9d09-5d43c86e97c0 Q2 TIDES GROUP, LLC 401105835 FREQUENCY THERAPEUTICS, INC. 2021 second_quarter MED Issues related to sensorineural hearing loss. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-16T17:43:33.283000-04:00
2641317 TIDES GROUP, LLC 1ded7ba0-6e05-461f-9325-4f2ab4ed7f03 Q2 TIDES GROUP, LLC 401105835 CATALENT PHARMA SOLUTIONS, LLC 2021 second_quarter MED Issues relating to pharmaceutical contract development manufacturing. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T17:45:36.720000-04:00
2641530 THE ROOSEVELT GROUP 9abd9fb8-aa3a-4f9a-9ca5-873d61a7a305 Q2 THE ROOSEVELT GROUP 400886595 LSU HEALTH SCIENCES FOUNDATION 2021 second_quarter MED Provide advocacy and support of research and development efforts inside the DoD and NIH HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-16T23:59:55.720000-04:00
2641585 REPUBLIC CONSULTING, LLC 401fd9e9-8164-4011-ab93-153f22cbe072 Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 second_quarter MED Monitored health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T09:41:27.690000-04:00
2641775 HAWLEY LLC 1bab19a1-3891-49fb-b1ef-bfb4b17f60a6 Q2 HAWLEY LLC 401105460 MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 second_quarter MED Issues related to pathogen testing for COVID 19 and other diseases. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 30000   0 0 2021-07-17T11:31:35.607000-04:00
2641845 TIBER CREEK GROUP f86610d8-fb51-4d76-a9c8-9ff8af548521 Q2 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2021 second_quarter MED Issues related to the FDA and S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T12:00:53.373000-04:00
2641907 FORBES-TATE 61ad6fc8-3f19-4317-b970-36d923005a1e Q2 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2021 second_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T12:45:11.357000-04:00
2642098 FORBES-TATE 53ff1e80-b560-4d50-9177-f0a7bc59aa14 Q2 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2021 second_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-17T14:25:57.337000-04:00
2642118 K&L GATES, LLP a70ff2f4-c344-4bee-b4bc-d1d686cedba4 Q2 K&L GATES, LLP 32098 CHEMBIO DIAGNOSTICS, INC. 2021 second_quarter MED Issues related to disease diagnostics testing and manufacturing - no specific legislation. SENATE 10000   0 0 2021-07-17T14:40:05.850000-04:00
2642122 FORBES-TATE 7ab3e9fc-b732-4c1f-a4a8-af3dd377f073 Q2 FORBES-TATE 400976792 CSL BEHRING 2021 second_quarter MED Issues related to COVID-19 response efforts. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T14:45:07.397000-04:00
2642184 THE PETRIZZO GROUP, INC. fcd08a3e-73ed-4e97-8ead-7654d0b62839 Q2 THE PETRIZZO GROUP, INC. 305932 ACCESS TO ADVANCED HEALTH INSTITUTE 2021 second_quarter MED Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; funding for flue vaccine, support adjuvant inclusion in COVID-19 countermeasures. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T15:10:27.660000-04:00
2642196 THE PETRIZZO GROUP, INC. c2c12b88-d3a0-42f3-b379-bb8dbc77db2b Q2 THE PETRIZZO GROUP, INC. 305932 IBIO, INC. 2021 second_quarter MED Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitization of domestic vaccine manufacturers that utilize agricultural cell line development for virus like particle based vaccines. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-17T15:14:31.387000-04:00
2642207 THE PETRIZZO GROUP, INC. 570f7f38-883d-4fad-9825-748be65d669d Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2021 second_quarter MED Pediatricians Accelerate Childhood Therapies Act of 2021 Increased NIH funding for pediatric research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T15:16:33.987000-04:00
2642225 CAPITOL COUNSEL LLC c6676808-7b2e-41b1-8138-f8f18a874722 Q2 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 second_quarter MED Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T15:21:38.317000-04:00
2642229 THE PETRIZZO GROUP, INC. 826d60a8-9fd8-41e4-b284-ede1c6cdbdc3 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2021 second_quarter MED Advancing initiatives to fund research of the immune system in underserved and understudied population communities to detect and prevent a downward spiral of vulnerable patients in this pandemic and future pandemics. Advocating for funding of research to develop a specialized suite of ethnically diverse and tissue-specific cell lines with accessible, stable, and reproducible human cell lines that are representative of our diverse population. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T15:22:39.240000-04:00
2642233 THE PETRIZZO GROUP, INC. 657627f0-72cf-4e8f-9340-fffd9e521dcc Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2021 second_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-07-17T15:23:40.680000-04:00
2642237 CAPITOL COUNSEL LLC 8ed4cf99-5eff-4d06-86ed-ea21667048be Q2 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2021 second_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-17T15:25:41.127000-04:00
2642331 BROWNSTEIN HYATT FARBER SCHRECK, LLP daacba43-661a-4766-b192-c404ed4f18dd Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ANTHEM, INC. 2021 second_quarter MED Issues related to the individual marketplace Health insurance tax and general tax issues Part D HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T16:15:13.300000-04:00
2642415 BROWNSTEIN HYATT FARBER SCHRECK, LLP a50f5a5e-4723-4696-8e91-a52fe7b87520 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 BAXTER HEALTHCARE CORPORATION 2021 second_quarter MED Availability of medical products Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 30000   0 0 2021-07-17T16:41:35.300000-04:00
2642472 FORBES-TATE d5d4963e-eaac-475c-8bb1-e5a70140fba0 Q2 FORBES-TATE 400976792 LUNDBECK LLC 2021 second_quarter MED Issues related to Mental health and Alzheimer's disease research; Issues related to the Food and Drug Administration; Issues related to protected class drug. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-17T17:22:53.440000-04:00
2642568 BROWNSTEIN HYATT FARBER SCHRECK, LLP 9b581158-253a-4840-ba3e-3712889e9535 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 COLUMBIA CARE LLC 2021 second_quarter MED Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-17T19:04:24.257000-04:00
2642615 KNIGHT CAPITOL CONSULTANTS f408199e-8239-4b34-be0b-ce6c0d414950 2A KNIGHT CAPITOL CONSULTANTS 40036301 PERSPECTUM 2021 second_quarter MED Food and Drug Administration regulation of medical devices, including Emergency Use Authorizations for critical products during the COVID-19 crisis. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2021-07-17T21:35:37.303000-04:00
2642753 FORBES-TATE 4224254a-e6ac-40b3-ba06-85e54b27e450 Q2 FORBES-TATE 400976792 NASH ALLIANCE COALITION 2021 second_quarter MED Issues related to the NASH Care Act - preventing, diagnosing, and treating nonalcoholic steatohepatitis. HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-18T10:36:20.730000-04:00
2642875 HOLLAND & KNIGHT LLP 246ca2d7-58f3-45e1-87a5-e6522518bbea Q2 HOLLAND & KNIGHT LLP 18466 PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION 2021 second_quarter MED Implementation of the over the counter drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Secretary (CARES Act); Implementation of Public Law 113-195, the Sunscreen Innovation Act; issues related to sunscreen use and coral reefs; National Academies of Sciences study on sunscreen; FDA environmental impact statement regarding sunscreen impact on the environment. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE 80000   0 0 2021-07-18T11:34:46.903000-04:00
2643217 BURRELL INTERNATIONAL GROUP LLC 4919aa0f-dba9-4c17-955d-3d15c99a1e9e 2T BURRELL INTERNATIONAL GROUP LLC 401103483 APCO WORLDWIDE LLC (ON BEHALF OF DETECTNOW F/K/A HOMODEUS DETECT) ) 2021 second_quarter MED Covid 19 Stimulus funding, biotechnology, LHHS Appropriations for NIH and BARDA diagnostic funding Committees: Appropriations HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2021-07-18T14:51:16.617000-04:00
2643229 VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) 0a3102c7-a826-489d-ba54-668e74a5cd05 Q2 VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) 401103475 CLINICAL REFERENCE LABORATORY, INC. 2021 second_quarter MED FDA approval process of COVID-19 related medical device and COVID-19 testing solutions. Food & Drug Administration (FDA),SENATE 60000   0 0 2021-07-18T14:54:21.513000-04:00
2643341 BROWNSTEIN HYATT FARBER SCHRECK, LLP 51547148-e5e1-4bcf-9cbb-fe7a996b62ae Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 INTERNATIONAL HEARING SOCIETY 2021 second_quarter MED Coverage of hearing healthcare under Medicare HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-18T15:50:55.543000-04:00
2643399 BROWNSTEIN HYATT FARBER SCHRECK, LLP 8e0b1139-37bc-4b98-ac91-22adb5c95028 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 MARIDOSE LLC 2021 second_quarter MED Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) Drug Enforcement Administration (DEA),SENATE 10000   0 0 2021-07-18T16:22:11.483000-04:00
2643485 BROWNSTEIN HYATT FARBER SCHRECK, LLP 2b94c216-e1a8-4d88-b58d-e7f3cb5196f2 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) 2021 second_quarter MED Issues related to the HIV/STD community; viral hepatitis funding; Appropriations Issues related to COVID-19 relief Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2021-07-18T17:02:38.997000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2492.034ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API